Fauci: Lack of full FDA approval for COVID-19 vaccines merely a 'technical issue'
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
You are now subscribed
Your newsletter sign-up was successful
Dr. Anthony Fauci, the United States' top infectious disease expert, said Sunday that Arkansas Gov. Asa Hutchinson (R) did "have a point" when he said COVID-19 vaccine hesitancy in his state can at least partly be attributed to the lack of full authorization for the shots from the Food and Drug Administration.
"There are certainly some people who, when you use the terminology 'emergency use authorization,' they kinda think it's ... tenuous data showing that it works so that it's safe," Fauci told ABC News' George Stephanopoulos on the latest edition of This Week. For some products that is indeed the case, but the Pfizer, Moderna, and Johnson & Johnson vaccines' safety and effectiveness are now supported by data taken from "hundreds of millions of people" from around the world, Fauci explained.
"So although it's understandable — quite understandable — that some people might say, well 'we want to wait for the full approval,' that's really only a technical issue," Fauci said. "It's the FDA dotting the I's and crossing the T's. But there's no doubt in my mind that these vaccines are going to get full approval because of the extraordinary amount of positive data."
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Regent Hong Kong: a tranquil haven with a prime waterfront spotThe Week Recommends The trendy hotel recently underwent an extensive two-year revamp
-
The problem with diagnosing profound autismThe Explainer Experts are reconsidering the idea of autism as a spectrum, which could impact diagnoses and policy making for the condition
-
What to know before filing your own taxes for the first timethe explainer Tackle this financial milestone with confidence
-
A Nipah virus outbreak in India has brought back Covid-era surveillanceUnder the radar The disease can spread through animals and humans
-
Trump HHS slashes advised child vaccinationsSpeed Read In a widely condemned move, the CDC will now recommend that children get vaccinated against 11 communicable diseases, not 17
-
Covid-19 mRNA vaccines could help fight cancerUnder the radar They boost the immune system
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
